Why do some patients succumb to their cancer in a matter of months, while others with the same disease live for years or even decades? These disparities, we now know, can be explained by the mutated genes and other abnormalities that drive a cancer’s growth and fuel its spread. Patients can increasingly be matched to precision therapies that target these aberrations.